Aryl cyclopropyl-amino-isoquinolinyl amide compounds
Provided herein are arylcyclopropyl amino-isoquinoline amide compounds. In particular, the disclosure provides compounds that affect the function of kinases in a cell and that are useful as therapeutic agents or with therapeutic agents. The compounds of the disclosure are useful in the treatment of a variety of diseases and conditions including eye diseases such as glaucoma, cardiovascular diseases, diseases characterized by abnormal growth, such as cancers, and inflammatory diseases. The disclosure further provides compositions containing isoquinoline amide compounds.
1. A compound, wherein the compound is:
or a pharmaceutically acceptable salt thereof.
2. A composition, comprising the compound of claim 1 .
3. A pharmaceutical composition, comprising the compound of claim 1 and a pharmaceutically acceptable carrier.